Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia
ABSTRACT: Background: Cutaneous leishmaniasis causes a high disease burden in Colombia, and available treatments present systemic toxicity, low patient compliance, contraindications, and high costs. The purpose of this study was to estimate the cost-effectiveness of thermotherapy versus Glucantime i...
- Autores:
-
Cardona Arias, Jaiberth Antonio
López Carvajal, Liliana
Tamayo Plata, Mery Patricia
Vélez Bernal, Iván Darío
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2018
- Institución:
- Universidad de Antioquia
- Repositorio:
- Repositorio UdeA
- Idioma:
- eng
- OAI Identifier:
- oai:bibliotecadigital.udea.edu.co:10495/23077
- Acceso en línea:
- http://hdl.handle.net/10495/23077
- Palabra clave:
- Evaluación de Costo-Efectividad
Cost-Effectiveness Evaluation
Leishmaniasis Cutánea
Leishmaniasis, Cutaneous
Hipertermia Inducida
Hyperthermia, Induced
Colombia
Gluconato de Sodio Antimonio
Antimony Sodium Gluconate
Termoterapia
Thermotheraphy
- Rights
- openAccess
- License
- https://creativecommons.org/licenses/by/4.0/
| id |
UDEA2_8388ce02b0616c2944b87786d89adf7c |
|---|---|
| oai_identifier_str |
oai:bibliotecadigital.udea.edu.co:10495/23077 |
| network_acronym_str |
UDEA2 |
| network_name_str |
Repositorio UdeA |
| repository_id_str |
|
| dc.title.spa.fl_str_mv |
Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia |
| title |
Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia |
| spellingShingle |
Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia Evaluación de Costo-Efectividad Cost-Effectiveness Evaluation Leishmaniasis Cutánea Leishmaniasis, Cutaneous Hipertermia Inducida Hyperthermia, Induced Colombia Gluconato de Sodio Antimonio Antimony Sodium Gluconate Termoterapia Thermotheraphy |
| title_short |
Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia |
| title_full |
Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia |
| title_fullStr |
Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia |
| title_full_unstemmed |
Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia |
| title_sort |
Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia |
| dc.creator.fl_str_mv |
Cardona Arias, Jaiberth Antonio López Carvajal, Liliana Tamayo Plata, Mery Patricia Vélez Bernal, Iván Darío |
| dc.contributor.author.none.fl_str_mv |
Cardona Arias, Jaiberth Antonio López Carvajal, Liliana Tamayo Plata, Mery Patricia Vélez Bernal, Iván Darío |
| dc.contributor.researchgroup.spa.fl_str_mv |
Programa de Estudio y Control de Enfermedades Tropicales (PECET) |
| dc.subject.decs.none.fl_str_mv |
Evaluación de Costo-Efectividad Cost-Effectiveness Evaluation Leishmaniasis Cutánea Leishmaniasis, Cutaneous Hipertermia Inducida Hyperthermia, Induced Colombia Gluconato de Sodio Antimonio Antimony Sodium Gluconate |
| topic |
Evaluación de Costo-Efectividad Cost-Effectiveness Evaluation Leishmaniasis Cutánea Leishmaniasis, Cutaneous Hipertermia Inducida Hyperthermia, Induced Colombia Gluconato de Sodio Antimonio Antimony Sodium Gluconate Termoterapia Thermotheraphy |
| dc.subject.lemb.none.fl_str_mv |
Termoterapia Thermotheraphy |
| description |
ABSTRACT: Background: Cutaneous leishmaniasis causes a high disease burden in Colombia, and available treatments present systemic toxicity, low patient compliance, contraindications, and high costs. The purpose of this study was to estimate the cost-effectiveness of thermotherapy versus Glucantime in patients with cutaneous leishmaniasis in Colombia. Methods: Cost-effectiveness study from an institutional perspective in 8133 incident cases. Data on therapeutic efficacy and safety were included, calculating standard costs; the outcomes were disability adjusted life years (DALYs) and the number of patients cured. The information sources were the Colombian Public Health Surveillance System, disease burden studies, and one meta-analysis of controlled clinical trials. Incremental cost-effectiveness was determined, and uncertainty was evaluated with tornado diagrams and Monte Carlo simulations. Results: Thermotherapy would generate costs of US$ 501,621; the handling of adverse effects, US$ 29,224; and therapeutic failures, US$ 300,053. For Glucantime, these costs would be US$ 2,731,276, US$ 58,254, and US$ 406,298, respectively. With thermotherapy, the cost would be US$ 2062 per DALY averted and US$ 69 per patient cured; with Glucantime, the cost would be US$ 4241 per DALY averted and US$ 85 per patient cured. In Monte Carlo simulations, thermotherapy was the dominant strategy for DALYs averted in 67.9% of cases and highly cost-effective for patients cured in 72%. Conclusion: In Colombia, thermotherapy can be included as a cost-effective strategy for the management of cutaneous leishmaniasis. Its incorporation into clinical practice guidelines could represent savings of approximately US$ 10,488 per DALY averted and costs of US$ 116 per additional patient cured, compared to the use of Glucantime. These findings show the relevance of the incorporation of this treatment in our country and others with similar parasitological, clinical, and epidemiological patterns. |
| publishDate |
2018 |
| dc.date.issued.none.fl_str_mv |
2018 |
| dc.date.accessioned.none.fl_str_mv |
2021-10-10T03:13:48Z |
| dc.date.available.none.fl_str_mv |
2021-10-10T03:13:48Z |
| dc.type.spa.fl_str_mv |
Artículo de investigación |
| dc.type.coar.spa.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
| dc.type.redcol.spa.fl_str_mv |
https://purl.org/redcol/resource_type/ART |
| dc.type.coarversion.spa.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.driver.spa.fl_str_mv |
info:eu-repo/semantics/article |
| dc.type.version.spa.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| format |
http://purl.org/coar/resource_type/c_2df8fbb1 |
| status_str |
publishedVersion |
| dc.identifier.uri.none.fl_str_mv |
http://hdl.handle.net/10495/23077 |
| dc.identifier.doi.none.fl_str_mv |
DOI 10.1186/s12889-018-5060-2 |
| dc.identifier.eissn.none.fl_str_mv |
1471-2458 |
| url |
http://hdl.handle.net/10495/23077 |
| identifier_str_mv |
DOI 10.1186/s12889-018-5060-2 1471-2458 |
| dc.language.iso.spa.fl_str_mv |
eng |
| language |
eng |
| dc.relation.ispartofjournalabbrev.spa.fl_str_mv |
BMC Public Health |
| dc.relation.citationendpage.spa.fl_str_mv |
12 |
| dc.relation.citationstartpage.spa.fl_str_mv |
1 |
| dc.relation.citationvolume.spa.fl_str_mv |
18 |
| dc.relation.ispartofjournal.spa.fl_str_mv |
BMC Public Health |
| dc.rights.uri.spa.fl_str_mv |
https://creativecommons.org/licenses/by/4.0/ |
| dc.rights.uri.*.fl_str_mv |
http://creativecommons.org/licenses/by/2.5/co/ |
| dc.rights.accessrights.spa.fl_str_mv |
info:eu-repo/semantics/openAccess |
| dc.rights.coar.spa.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/2.5/co/ http://purl.org/coar/access_right/c_abf2 |
| eu_rights_str_mv |
openAccess |
| dc.format.extent.spa.fl_str_mv |
11 |
| dc.format.mimetype.spa.fl_str_mv |
application/pdf |
| dc.publisher.spa.fl_str_mv |
BMC |
| dc.publisher.place.spa.fl_str_mv |
Londres, Inglaterra |
| institution |
Universidad de Antioquia |
| bitstream.url.fl_str_mv |
https://bibliotecadigital.udea.edu.co/bitstreams/2b41f91c-dad0-4866-9b16-457fd16ecd4c/download https://bibliotecadigital.udea.edu.co/bitstreams/c985eba7-c2e4-4727-8415-30307ccf77b2/download https://bibliotecadigital.udea.edu.co/bitstreams/41fa1ed7-3115-4627-9866-ce0abd3f97fd/download https://bibliotecadigital.udea.edu.co/bitstreams/ddf77f3f-c7ab-4e4f-af8a-fcbf3802dffa/download https://bibliotecadigital.udea.edu.co/bitstreams/fe899be3-3cad-4ec6-8087-53fce7ba5649/download |
| bitstream.checksum.fl_str_mv |
1646d1f6b96dbbbc38035efc9239ac9c 8a4605be74aa9ea9d79846c1fba20a33 ba05787a27d5d8c5aaa295d843c3e818 564a9ebfa0d950838ce2b7c2913e1229 18a1ae07eaa48d60524d6dfa1322500b |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositorio Institucional de la Universidad de Antioquia |
| repository.mail.fl_str_mv |
aplicacionbibliotecadigitalbiblioteca@udea.edu.co |
| _version_ |
1851052559256518656 |
| spelling |
Cardona Arias, Jaiberth AntonioLópez Carvajal, LilianaTamayo Plata, Mery PatriciaVélez Bernal, Iván DaríoPrograma de Estudio y Control de Enfermedades Tropicales (PECET)2021-10-10T03:13:48Z2021-10-10T03:13:48Z2018http://hdl.handle.net/10495/23077DOI 10.1186/s12889-018-5060-21471-2458ABSTRACT: Background: Cutaneous leishmaniasis causes a high disease burden in Colombia, and available treatments present systemic toxicity, low patient compliance, contraindications, and high costs. The purpose of this study was to estimate the cost-effectiveness of thermotherapy versus Glucantime in patients with cutaneous leishmaniasis in Colombia. Methods: Cost-effectiveness study from an institutional perspective in 8133 incident cases. Data on therapeutic efficacy and safety were included, calculating standard costs; the outcomes were disability adjusted life years (DALYs) and the number of patients cured. The information sources were the Colombian Public Health Surveillance System, disease burden studies, and one meta-analysis of controlled clinical trials. Incremental cost-effectiveness was determined, and uncertainty was evaluated with tornado diagrams and Monte Carlo simulations. Results: Thermotherapy would generate costs of US$ 501,621; the handling of adverse effects, US$ 29,224; and therapeutic failures, US$ 300,053. For Glucantime, these costs would be US$ 2,731,276, US$ 58,254, and US$ 406,298, respectively. With thermotherapy, the cost would be US$ 2062 per DALY averted and US$ 69 per patient cured; with Glucantime, the cost would be US$ 4241 per DALY averted and US$ 85 per patient cured. In Monte Carlo simulations, thermotherapy was the dominant strategy for DALYs averted in 67.9% of cases and highly cost-effective for patients cured in 72%. Conclusion: In Colombia, thermotherapy can be included as a cost-effective strategy for the management of cutaneous leishmaniasis. Its incorporation into clinical practice guidelines could represent savings of approximately US$ 10,488 per DALY averted and costs of US$ 116 per additional patient cured, compared to the use of Glucantime. These findings show the relevance of the incorporation of this treatment in our country and others with similar parasitological, clinical, and epidemiological patterns.COL001509911application/pdfengBMCLondres, Inglaterrahttps://creativecommons.org/licenses/by/4.0/http://creativecommons.org/licenses/by/2.5/co/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in ColombiaArtículo de investigaciónhttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARThttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionEvaluación de Costo-EfectividadCost-Effectiveness EvaluationLeishmaniasis CutáneaLeishmaniasis, CutaneousHipertermia InducidaHyperthermia, InducedColombiaGluconato de Sodio AntimonioAntimony Sodium GluconateTermoterapiaThermotheraphyBMC Public Health12118BMC Public HealthPublicationCC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8927https://bibliotecadigital.udea.edu.co/bitstreams/2b41f91c-dad0-4866-9b16-457fd16ecd4c/download1646d1f6b96dbbbc38035efc9239ac9cMD52falseAnonymousREADLICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstreams/c985eba7-c2e4-4727-8415-30307ccf77b2/download8a4605be74aa9ea9d79846c1fba20a33MD53falseAnonymousREADORIGINALJaiberthCardona_2018_Comprehensivethermotherapyleishmaniasis.pdfJaiberthCardona_2018_Comprehensivethermotherapyleishmaniasis.pdfArtículo de investigaciónapplication/pdf1237778https://bibliotecadigital.udea.edu.co/bitstreams/41fa1ed7-3115-4627-9866-ce0abd3f97fd/downloadba05787a27d5d8c5aaa295d843c3e818MD51trueAnonymousREADTEXTJaiberthCardona_2018_Comprehensivethermotherapyleishmaniasis.pdf.txtJaiberthCardona_2018_Comprehensivethermotherapyleishmaniasis.pdf.txtExtracted texttext/plain46723https://bibliotecadigital.udea.edu.co/bitstreams/ddf77f3f-c7ab-4e4f-af8a-fcbf3802dffa/download564a9ebfa0d950838ce2b7c2913e1229MD54falseAnonymousREADTHUMBNAILJaiberthCardona_2018_Comprehensivethermotherapyleishmaniasis.pdf.jpgJaiberthCardona_2018_Comprehensivethermotherapyleishmaniasis.pdf.jpgGenerated Thumbnailimage/jpeg14529https://bibliotecadigital.udea.edu.co/bitstreams/fe899be3-3cad-4ec6-8087-53fce7ba5649/download18a1ae07eaa48d60524d6dfa1322500bMD55falseAnonymousREAD10495/23077oai:bibliotecadigital.udea.edu.co:10495/230772025-03-27 00:18:45.682https://creativecommons.org/licenses/by/4.0/open.accesshttps://bibliotecadigital.udea.edu.coRepositorio Institucional de la Universidad de Antioquiaaplicacionbibliotecadigitalbiblioteca@udea.edu.coTk9URTogUExBQ0UgWU9VUiBPV04gTElDRU5TRSBIRVJFClRoaXMgc2FtcGxlIGxpY2Vuc2UgaXMgcHJvdmlkZWQgZm9yIGluZm9ybWF0aW9uYWwgcHVycG9zZXMgb25seS4KCk5PTi1FWENMVVNJVkUgRElTVFJJQlVUSU9OIExJQ0VOU0UKCkJ5IHNpZ25pbmcgYW5kIHN1Ym1pdHRpbmcgdGhpcyBsaWNlbnNlLCB5b3UgKHRoZSBhdXRob3Iocykgb3IgY29weXJpZ2h0Cm93bmVyKSBncmFudHMgdG8gRFNwYWNlIFVuaXZlcnNpdHkgKERTVSkgdGhlIG5vbi1leGNsdXNpdmUgcmlnaHQgdG8gcmVwcm9kdWNlLAp0cmFuc2xhdGUgKGFzIGRlZmluZWQgYmVsb3cpLCBhbmQvb3IgZGlzdHJpYnV0ZSB5b3VyIHN1Ym1pc3Npb24gKGluY2x1ZGluZwp0aGUgYWJzdHJhY3QpIHdvcmxkd2lkZSBpbiBwcmludCBhbmQgZWxlY3Ryb25pYyBmb3JtYXQgYW5kIGluIGFueSBtZWRpdW0sCmluY2x1ZGluZyBidXQgbm90IGxpbWl0ZWQgdG8gYXVkaW8gb3IgdmlkZW8uCgpZb3UgYWdyZWUgdGhhdCBEU1UgbWF5LCB3aXRob3V0IGNoYW5naW5nIHRoZSBjb250ZW50LCB0cmFuc2xhdGUgdGhlCnN1Ym1pc3Npb24gdG8gYW55IG1lZGl1bSBvciBmb3JtYXQgZm9yIHRoZSBwdXJwb3NlIG9mIHByZXNlcnZhdGlvbi4KCllvdSBhbHNvIGFncmVlIHRoYXQgRFNVIG1heSBrZWVwIG1vcmUgdGhhbiBvbmUgY29weSBvZiB0aGlzIHN1Ym1pc3Npb24gZm9yCnB1cnBvc2VzIG9mIHNlY3VyaXR5LCBiYWNrLXVwIGFuZCBwcmVzZXJ2YXRpb24uCgpZb3UgcmVwcmVzZW50IHRoYXQgdGhlIHN1Ym1pc3Npb24gaXMgeW91ciBvcmlnaW5hbCB3b3JrLCBhbmQgdGhhdCB5b3UgaGF2ZQp0aGUgcmlnaHQgdG8gZ3JhbnQgdGhlIHJpZ2h0cyBjb250YWluZWQgaW4gdGhpcyBsaWNlbnNlLiBZb3UgYWxzbyByZXByZXNlbnQKdGhhdCB5b3VyIHN1Ym1pc3Npb24gZG9lcyBub3QsIHRvIHRoZSBiZXN0IG9mIHlvdXIga25vd2xlZGdlLCBpbmZyaW5nZSB1cG9uCmFueW9uZSdzIGNvcHlyaWdodC4KCklmIHRoZSBzdWJtaXNzaW9uIGNvbnRhaW5zIG1hdGVyaWFsIGZvciB3aGljaCB5b3UgZG8gbm90IGhvbGQgY29weXJpZ2h0LAp5b3UgcmVwcmVzZW50IHRoYXQgeW91IGhhdmUgb2J0YWluZWQgdGhlIHVucmVzdHJpY3RlZCBwZXJtaXNzaW9uIG9mIHRoZQpjb3B5cmlnaHQgb3duZXIgdG8gZ3JhbnQgRFNVIHRoZSByaWdodHMgcmVxdWlyZWQgYnkgdGhpcyBsaWNlbnNlLCBhbmQgdGhhdApzdWNoIHRoaXJkLXBhcnR5IG93bmVkIG1hdGVyaWFsIGlzIGNsZWFybHkgaWRlbnRpZmllZCBhbmQgYWNrbm93bGVkZ2VkCndpdGhpbiB0aGUgdGV4dCBvciBjb250ZW50IG9mIHRoZSBzdWJtaXNzaW9uLgoKSUYgVEhFIFNVQk1JU1NJT04gSVMgQkFTRUQgVVBPTiBXT1JLIFRIQVQgSEFTIEJFRU4gU1BPTlNPUkVEIE9SIFNVUFBPUlRFRApCWSBBTiBBR0VOQ1kgT1IgT1JHQU5JWkFUSU9OIE9USEVSIFRIQU4gRFNVLCBZT1UgUkVQUkVTRU5UIFRIQVQgWU9VIEhBVkUKRlVMRklMTEVEIEFOWSBSSUdIVCBPRiBSRVZJRVcgT1IgT1RIRVIgT0JMSUdBVElPTlMgUkVRVUlSRUQgQlkgU1VDSApDT05UUkFDVCBPUiBBR1JFRU1FTlQuCgpEU1Ugd2lsbCBjbGVhcmx5IGlkZW50aWZ5IHlvdXIgbmFtZShzKSBhcyB0aGUgYXV0aG9yKHMpIG9yIG93bmVyKHMpIG9mIHRoZQpzdWJtaXNzaW9uLCBhbmQgd2lsbCBub3QgbWFrZSBhbnkgYWx0ZXJhdGlvbiwgb3RoZXIgdGhhbiBhcyBhbGxvd2VkIGJ5IHRoaXMKbGljZW5zZSwgdG8geW91ciBzdWJtaXNzaW9uLgo= |
